日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Surface hydrophobicity and rigidity determines protein corona on orally delivered nanoparticles treating colitis.

表面疏水性和刚性决定了口服纳米颗粒治疗结肠炎时表面的蛋白质冠层。

Wu Jiawei, Ni Mingjie, Xing Liyun, Wang Yating, Liu Xi, Zheng Yaxian, Li Lian, Huang Yuan

Macrophage Nrf1/NFE2L1-Foxo1 axis controls liver fibrosis by modulation of mitochondrial reprogramming

巨噬细胞Nrf1/NFE2L1-Foxo1轴通过调节线粒体重编程控制肝纤维化

Lin, Yuanbang; Bian, Xiyun; Yao, Yao; Xu, Jingman; Cao, Yingli; Wu, Qiong; Ning, Wen; Li, Lian; Sheng, Mingwei; Wang, Fengmei

Targeting mitocytosis potentiates mitochondria drug delivery for antimetastasis therapy.

靶向线粒体胞吐作用可增强线粒体药物递送,用于抗转移治疗。

Deng Yudi, Zhang Yunhui, Jia Fuya, Jiang Peihang, Li Lian, Huang Yuan

Targeted Nanoboron Delivery Platform for Boron Neutron Capture Therapy in Refractory Solid Tumors

用于难治性实体瘤硼中子俘获疗法的靶向纳米硼递送平台

Ma, Zhenchao; Ma, Ziyan; Wang, Xinlin; Li, Yaru; Li, Lian; Li, Luzixuan; Ji, Peng; Yan, Qiang

Mitochondria-targeted delivery strategies for age-related diseases

针对老年相关疾病的线粒体靶向递送策略

Liu, Zefan; Yang, Pei; Cheng, Guilin; Kang, Xin; Li, Lian; Xiang, Yucheng

Interactive effect of social isolation and poor nutritional status on cognitive function decline in older adults

社会孤立和营养不良对老年人认知功能下降的交互作用

Li, Lian; Xiao, Sa; Zhang, Zile; Yang, Hongying; Tao, Yumin

Bitter Chinese Herbal Medicine Exerts Pharmacological Effects via TAS2Rs: A Systematic Review from Natural Ligands to Therapeutic Potential

苦味中药通过TAS2R发挥药理作用:从天然配体到治疗潜力的系统综述

Li, Lian; Dong, Ruitong; Feng, Shibu; Huang, Yan; Li, Xin; Que, Hanyun; Li, Huan; Wang, Peng; Fey, Leu-Kim; Zhang, Yi; Cong, Zhaotong; Zhang, Sanyin

Multi-omics analysis of the gut-liver axis revealed the effects of different exercise interventions in NAFLD mice

对肠-肝轴的多组学分析揭示了不同运动干预对非酒精性脂肪性肝病小鼠的影响

Hu, Chao-Rui; Zeng, Chuan-Fei; Li, Huan; Wei, Mingliang; Liu, Shi-Qian; Li, Lian-Yun; Xiao, Yong; Wu, Min; Chen, Ming-Kai

SeSA-HCPT: A dual-targeting agent that induces DNA damage and inhibits repair for castration-resistant prostate cancer therapy

SeSA-HCPT:一种双靶向药物,可诱导DNA损伤并抑制修复,用于治疗去势抵抗性前列腺癌。

Wang, Yajie; Wang, Qiuyu; Meng, Li; Lian, Xiaoying; Wu, Xinyue; Wang, Yuqing; Zhang, Tianyu; Wei, ShiLin; Wang, Yanming; Zhu, Changjun

Tracking global quality of life trajectories in knee osteoarthritis: a population-based long-term analysis

追踪膝骨关节炎患者全球生活质量轨迹:一项基于人群的长期分析

Fu, Fanyu; Dong, Li; Lian, Jiwei; Liu, Chang; Pang, Tingting; Wang, Yunli; Liu, Peng; Wang, Yufeng